Sort
261,768 grants matching “gene therapy”
Epidemiology of Ovarian Cancer in African-American Women
$1,228,381Joellen M. Schildkraut · University Of Virginia · R01 · FY2015 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$1,228,372Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial
$1,228,271Nisha Acharya · University Of California, San Francisco · UG1 · FY2022 · EY
The role of PKD proteins in regulating tubular morphology
$1,228,262Gregory Germino · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
GENE THERAPY FOR MALIGNANT MESOTHELIOMA
$1,228,233University Of Pennsylvania · P01 · FY2000 · CA
Novel 5-HT7 Antagonists for the treatment of inflammatory bowel disease
$1,228,145Douglas Anthony Pippin · Praeventix, Llc · R44 · FY2018 · DK
Novel 5-HT7 Antagonists for the treatment of inflammatory bowel disease
$1,228,145Douglas Anthony Pippin · Praeventix, Llc · R44 · FY2019 · DK
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology
$1,227,787Rosa Rademakers · Mayo Clinic Jacksonville · UH3 · FY2019 · NS
Genetic and Molecular Epidemiology of Adult Glioma
$1,227,655Margaret R. Wrensch · University Of California, San Francisco · R01 · FY2006 · CA
Diagnosis, Pathophysiology And Molecular Biology Of Pheochromocytoma
$1,227,520Karel Pacak · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
PROgenitor Cell Release Plus Exercise To Improve Functional Performance In PAD
$1,227,493Mary McGrae McDermott · Northwestern University At Chicago · R01 · FY2014 · HL
The essential roles of primary cilia in heterotopic ossification
$1,227,374Haitao Wang · Mayo Clinic Rochester · R01 · FY2025 · AR
The connection of innate and adaptive anti-cancer immunity
$1,227,316John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
RNA interference-based screens for molecular targets in cancer
$1,226,826Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Molecular diagnosis and outcome prediction in lymphoma
$1,226,826Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$1,226,826Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
An immune-based approach for HIV eradication
$1,226,363Juan Lama · Retrovirox, Inc. · R44 · FY2016 · AI
Immunobiology of Tolerance FF Allogeneic Hematopoietic Cell Transplantation
$1,226,354John Andrew Hansen · Fred Hutchinson Cancer Research Center · P01 · FY2009 · AI
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
$1,226,317Krista H Vandenborne · University Of Florida · R01 · FY2024 · AR
A "Trojan Horse" bispecific antibody strategy for broad filovirus therapeutics
$1,226,238Kartik Chandran · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,226,023Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis
$1,225,995Ramon Bataller · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · AA
Pediatric Oncology Branch Behavioral Science Core
$1,225,916John Glod · Division Of Basic Sciences - Nci · ZID · FY2022 · CA
Protein Expression Facility
$1,225,897Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2019 · ES
Immunology of Acute and Chronic Viral Hepatitis
$1,225,798Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK